Venture NAV Tracker / Private company
Phathom Pharmaceuticals, Inc.
Headquarters—
Founded—
Last known round—
Reported valuation—
+972.8% equity-mark dispersion. Hercules Capital, Inc. carries Phathom Pharmaceuticals, Inc. at $1.04/share; Hercules Capital, Inc. carries it at $11.11/share. Review dates and security types before treating those marks as directly comparable.
Cross-fund comparison
Equity & warrant marks
One latest disclosed mark per fund.
| Fund | Fair value | Security / basis | Implied price / share | Mark age vs round | Methodology / filing |
|---|---|---|---|---|---|
| HTGCHercules Capital, Inc. | $1.6MMar 31, 2026 · source ↗ | equityFair Value | $11.11Not comparable — different security type or share classMar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | 10-Q 2026-03-31 ↗ |
| HTGCHercules Capital, Inc. | $67KMar 31, 2026 · source ↗ | warrantFair Value | $1.04Not comparable — different security type or share classMar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | 10-Q 2026-03-31 ↗ |
Cross-fund comparison
Debt investments
One latest disclosed debt mark per fund.
| Fund | Security type / basis | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| HTGCHercules Capital, Inc. | senior secured loanFair Value — Senior Secured | $133.1MMar 31, 2026 · source ↗ | $132.5MMar 31, 2026 · source ↗ | 99.5%Mar 31, 2026 · source ↗ | Prime + 3.10 %, Floor rate 9.85 %, 2.00 % Exit FeeMar 31, 2026 · source ↗ | Feb 1, 2029Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.